General Information of Drug (ID: DMSVQMO)

Drug Name
PMID25656651-Compound-31a Drug Info
Cross-matching ID
PubChem CID
56599744
TTD Drug ID
DMSVQMO

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Patented Agent(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
PMID25656651-Compound-37b DMX98YV N. A. N. A. Patented [1]
PMID25656651-Compound-36a DMNXVY9 N. A. N. A. Patented [1]
PMID25656651-Compound-37c DM684IK N. A. N. A. Patented [1]
PMID25656651-Compound-36d DMKMY4I N. A. N. A. Patented [1]
PMID25656651-Compound-36b DMHYDM7 N. A. N. A. Patented [1]
PMID25656651-Compound-36c DMOGKSW N. A. N. A. Patented [1]
PMID25656651-Compound-19b DMI1Z7D N. A. N. A. Patented [1]
PMID25656651-Compound-37a DM0P4F3 N. A. N. A. Patented [1]
PMID25656651-Compound-19a DMSNUVZ N. A. N. A. Patented [1]
Indazole derivative 5 DMM1I8R N. A. N. A. Patented [1]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Fusion protein Bcr-Abl T315I mutant (Bcr-Abl T315I) TTIV39N BCR_HUMAN-ABL1_HUMAN Inhibitor [1]

References

1 Bcr-Abl tyrosine kinase inhibitors: a patent review.Expert Opin Ther Pat. 2015 Apr;25(4):397-412.